Everest Organics Limited (EVERESTO.BO)
INR 402.45
(3.13%)
INR 402.45
(3.13%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.97 Billion INR | 7.75% |
| 2022 | 1.83 Billion INR | -8.5% |
| 2021 | 2 Billion INR | 10.18% |
| 2020 | 1.81 Billion INR | 8.58% |
| 2019 | 1.67 Billion INR | 7.29% |
| 2018 | 1.55 Billion INR | 38.94% |
| 2017 | 1.12 Billion INR | 4.94% |
| 2016 | 1.06 Billion INR | 7.21% |
| 2015 | 997.07 Million INR | -6.09% |
| 2014 | 1.06 Billion INR | 10.0% |
| 2013 | 965.15 Million INR | 21.2% |
| 2012 | 796.35 Million INR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 324.45 Million INR | -38.34% |
| 2023 Q4 | 526.16 Million INR | 0.21% |
| 2023 Q3 | 525.07 Million INR | 6.19% |
| 2023 FY | 1.97 Billion INR | 7.75% |
| 2023 Q1 | 426.69 Million INR | -15.93% |
| 2023 Q2 | 494.47 Million INR | 15.88% |
| 2022 FY | 1.83 Billion INR | -8.5% |
| 2022 Q1 | 430.28 Million INR | -21.91% |
| 2022 Q2 | 459.72 Million INR | 6.84% |
| 2022 Q3 | 432.94 Million INR | -5.82% |
| 2022 Q4 | 507.53 Million INR | 17.23% |
| 2021 Q3 | 468.7 Million INR | 0.26% |
| 2021 Q1 | 513.28 Million INR | 13.96% |
| 2021 FY | 2 Billion INR | 10.18% |
| 2021 Q2 | 467.49 Million INR | -8.92% |
| 2021 Q4 | 550.98 Million INR | 17.56% |
| 2020 Q4 | 450.41 Million INR | -6.93% |
| 2020 FY | 1.81 Billion INR | 8.58% |
| 2020 Q3 | 483.98 Million INR | 7.32% |
| 2020 Q2 | 450.96 Million INR | 3.95% |
| 2020 Q1 | 433.84 Million INR | -6.01% |
| 2019 FY | 1.67 Billion INR | 7.29% |
| 2019 Q2 | 401.94 Million INR | -3.06% |
| 2019 Q1 | 414.64 Million INR | -20.73% |
| 2019 Q3 | 400.93 Million INR | -0.25% |
| 2019 Q4 | 461.59 Million INR | 15.13% |
| 2018 Q3 | 400.81 Million INR | 9.6% |
| 2018 Q2 | 365.72 Million INR | 33.97% |
| 2018 Q1 | 272.98 Million INR | -15.5% |
| 2018 Q4 | 523.08 Million INR | 30.51% |
| 2018 FY | 1.55 Billion INR | 38.94% |
| 2017 Q1 | 244.67 Million INR | -3.44% |
| 2017 Q4 | 323.03 Million INR | 19.52% |
| 2017 FY | 1.12 Billion INR | 4.94% |
| 2017 Q3 | 270.28 Million INR | -5.98% |
| 2017 Q2 | 287.47 Million INR | 17.49% |
| 2016 Q4 | 253.38 Million INR | -8.57% |
| 2016 FY | 1.06 Billion INR | 7.21% |
| 2016 Q1 | 245.17 Million INR | -13.88% |
| 2016 Q2 | 294.56 Million INR | 20.14% |
| 2016 Q3 | 277.14 Million INR | -5.92% |
| 2015 Q1 | 254.62 Million INR | -16.78% |
| 2015 Q3 | 232.87 Million INR | 3.55% |
| 2015 Q2 | 224.87 Million INR | -11.68% |
| 2015 Q4 | 284.7 Million INR | 22.26% |
| 2015 FY | 997.07 Million INR | -6.09% |
| 2014 Q4 | 305.95 Million INR | 9.5% |
| 2014 Q3 | 279.41 Million INR | 14.41% |
| 2014 FY | 1.06 Billion INR | 10.0% |
| 2014 Q2 | 244.22 Million INR | 0.0% |
| 2013 Q4 | 285.96 Million INR | 21.39% |
| 2013 Q1 | 204.71 Million INR | 2.24% |
| 2013 Q3 | 235.57 Million INR | -1.39% |
| 2013 FY | 965.15 Million INR | 21.2% |
| 2013 Q2 | 238.89 Million INR | 16.7% |
| 2012 FY | 796.35 Million INR | 0.0% |
| 2012 Q4 | 200.23 Million INR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 2.22 Billion INR | 11.353% |
| Checkpoint Trends Limited | 11.3 Million INR | -17340.551% |
| GUJARAT INJECT (KERALA) LTD. | 57.88 Million INR | -3307.558% |
| NATURO INDIABULL LIMITED | 418.93 Million INR | -370.819% |
| NEXUS SURGICAL AND MEDICARE LI | 34.74 Million INR | -5577.263% |
| Rajnish Wellness Limited | 766.84 Million INR | -157.211% |
| Rama Vision Limited | 895.7 Million INR | -120.208% |
| Vivo Bio Tech Limited | 454.51 Million INR | -333.963% |